Remove Biopharma Remove Healthcare Remove Healthcare Provider Remove Patients
article thumbnail

Access solutions: the missing link that prevents biopharma innovation from reaching patients

pharmaphorum

Science has taken a vertical growth trajectory, yet such innovations are, at best, slow to reach the patients in need. We believe that innovation in patient access models is the necessary catalyst to aid patients in starting on and staying on the therapies they need to improve their lives.

article thumbnail

Elite 2024 Disrupter Bryan Johnson of Veeva Systems

PM360

Bryan Johnson Senior Director, Product Management, Compass Prescriber Veeva Systems Paving the Way to Faster Treatment Starts Bryan’s exposure to life sciences started at a young age, watching his father’s career at companies like Johnson & Johnson and emerging biopharmas. As rare diseases affect about 1 in 10 people in the U.S.,

Retail 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How retailers and “payviders” are disrupting U.S. healthcare in 2024

Clarivate

While the key players’ strategies differ, all are focused on bending the cost curve while increasing patient touchpoints and engagement. Strategy #1: innovate and create Amazon founder Jeff Bezos has said that overnight success takes about 10 years — and that ramp-up period may be what’s playing out for the ecommerce giant in healthcare.

Retail 52
article thumbnail

FOCUS ON: Connected TV

PM360

From connecting with patients by interactive ads to dabbling into cross-platform integration, here is what our specialists had to say. What are new and effective ways of engaging patients who are now using streaming services? Biopharma marketers are following their audiences and investment in this channel continues to increase.

Media 52
article thumbnail

Navigating the rapidly changing oncology treatment landscape: how digital tools can help

Impetus Digital

In fact, for the past five years, the number of treated patients with cancer has seen an average annual increase of 5% globally (1). This competitive intensity tends to focus on smaller patient populations with multiple treatment options (1,2). However, with rapid growth comes growing pains.

article thumbnail

AmerisourceBergen introduces CGT integration hub

Pharmaceutical Technology

Global healthcare company AmerisourceBergen has launched a cell and gene therapy (CGT) integration hub. The new system can be integrated with biopharma or provider-facing platforms to enable the exchange of information in real time.

article thumbnail

U.S. market access landscape: A push for control is erasing the boundary between payers and providers in U.S. healthcare

Clarivate

healthcare payers and providers are consolidating at a dizzying clip as they seek to gain market share, increase access to care and secure clinical control to improve health outcomes. billion deal to acquire Oak Street Health, a value-based primary-care company focused on treating Medicare patients.